Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, and Organ Transplantation Techniques and Outcomes.
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injury
Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity
Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a <scp>TIPS</scp>
Ammonia Levels After Transjugular Intrahepatic Portosystemic Shunt Insertion Identify Patients at High Risk of Hepatic Encephalopathy
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab
Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study
QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis
PHES scores have limited impact on the risk of overt HE in patients with minimal HE
Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study
Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with Cirrhosis
Higher scores in the Clinical Frailty Scale are associated with covert and overt hepatic encephalopathy in patients with cirrhosis
Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimates
Development and evaluation of a virtual reality driving test for patients with cirrhosis
Plasma exchange for treatment of a therapy‐related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma—A case report
Emerging immunotherapy for HCC: A guide for hepatologists
Review article: post‐<scp>TIPSS</scp> hepatic encephalopathy—current knowledge and future perspectives
Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC
Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany
Diabetes mellitus – risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?
A higher FIB‐4 index is associated with an increased incidence of renal failure in the general population
Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis